Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional Candida antigen immunotherapy for molluscum contagiosum
IRCT20180411039265N2Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Aug 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of candida albicans antigen in molluscum contagiosum (MC), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Complete response, Relative response and 1 more. Started Aug 2018; status: completed.
02
Drugs
candida albicans antigen
03
Conditions
molluscum contagiosum (MC)
Beyond the preview
Go deeper on IRCT20180411039265N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180411039265N2.